Archives

by in
Entry Author Date Location
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche” 01/02/14 Boston
Red (and Green) Flags To Look for With Biotech’s Buyside Investors 10/31/13 Boston
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
Starting a Company Is Hard. Good Health Insurance Makes It Easier. 08/30/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Can (Should?) A Young Biotech Company Still Go Long? 12/20/12 Boston
UCSF Spinout Principia Biopharma Thinking Big and Covalent 10/30/12 San Francisco
Join Us Today for a Tweetchat at Noon ET/9 am PT With Katrine Bosley 06/19/12 National
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
Xconomy Boston’s Top 20 Stories of Q1: Editor’s Picks 04/02/12 Boston
Celgene Pours $15M Into Acetylon, Takes “Observer” Role on Board 02/09/12 Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News 02/01/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
Celgene Acquires Avila Therapeutics for $350,000,000 01/27/12 Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere 01/26/12 Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Avila Shows Progress in Covalent Cancer Drugs at Prominent ASH Confab 12/12/11 Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
How Sanofi Could Start Off on the Right Foot in Cambridge 02/07/11 Boston
Dana-Farber Scientists Leave Board of Startup in Legal Battle with Cancer Center 01/21/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 12/27/10 Boston
EveryScape and Bing Expand Partnership, Raytheon Acquires Applied Signal, Avila Inks Sanofi Deal, & More Boston-Area Deals News 12/22/10 Boston
Sanofi Taps Avila Therapeutics for Covalent Cancer Drugs in Potential $800M Deal 12/20/10 Boston
Novartis Takes Aim at Bay-Area Biotech with Dana-Farber Roots in Legal Battle Over Potential Lung Cancer Drugs 12/02/10 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit 11/12/10 Boston
Page 1 of 2 next page »